AiM Medical Robotics is a neurosurgical robotics company founded in 2018, with the mission of improving outcomes for patients undergoing neurosurgery for functional brain disorders (Parkinson’s, Epilepsy, etc.) and Glioblastoma. The company's slogan "Enabling physicians to hit their targets the first time, every time" highlights the precision and efficiency they aim to bring to the surgical suite.
Their innovative approach involves introducing portable MRI-functional robotics into the complex surgical environment of neurosurgery. This includes the development of a portable neurosurgical robot for use in the MRI scanner, promising high levels of precision, automation, and efficiency.
With a recent Venture Round investment at 22 August 2022 from the Sontag Family Trust, AiM Medical Robotics is poised to further their advancements in the fields of biotechnology and robotics. Their efforts not only aim to enhance patient outcomes, particularly in neurosurgery, but also to provide cost savings to hospitals by reducing procedure time by up to 50% and eliminating errors. Based in the United States, their pioneering work signifies a significant stride in the intersection of medical technology and robotics.
No recent news or press coverage available for AiM Medical Robotics.